Interleukin-4 -590T/C polymorphism influences the susceptibility to nonsmall cell lung cancer

DNA and Cell Biology

Volumn 31, Issue 5, 2012, Pages 797-800

  Li, Xiaoyan ^a   Shi, Weiwei ^b   Yu, Guanzhen ^c   Lin, Li ^a   Yang, Bo ^b   Li, Jianxiong ^b   Guo, Wanfeng ^a   Tang, Chuanhao ^a   Wang, Hong ^a   Gao, Hongjun ^a   Qin, Haifeng ^a   Liu, Yi ^a   Liu, Xiaoqing ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-4; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 84861414246     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1425     Document Type: Article

References (24)

1. Amsen, D., Spilianakis, C.G., and Flavell, R.A. (2009).Howare T(H)1 and T(H)2 effector cells made? Curr Opin Immunol 21, 153-160.
2. Bai, J., Lin,M.,Zeng, X.,Zhang,Y.,Wang,Z., Shen, J., Jiang, L.,Gao, F., and Chen, Q. (2008). Association of polymorphisms in the human IFN-gamma and IL-4 genewith oral lichen planus: a study in an ethnic Chinese cohort. J Interferon Cytokine Res 28, 351-358. (Pubitemid 351929934)
3. Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J., and Schreiber, R.D. (2002). Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991-998. (Pubitemid 35363648)
4. Groome, P.A., Bolejack, V., Crowley, J.J., Kennedy, C., Krasnik, M., Sobin, L.H., and Goldstraw, P. (2007). The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol 2, 694-705. (Pubitemid 47357521)
5. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
6. Ishikawa, M., Kitayama, J., Yamauchi, T., Kadowaki, T., Maki, T., and Miyato, H. (2007). Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptorsAdipoR1 andAdipoR2. Cancer Sci 98, 1120-1127. (Pubitemid 46865400)
7. Kawakami, M., Kawakami, K., Stepensky, V.A., Maki, R.A., Robin, H., Muller, W., Husain, S.R., and Puri, R.K. (2002). Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy. Clin Cancer Res 8, 3503-3511. (Pubitemid 35340728)
8. Kelso, A. (1998). Cytokines: principles and prospects. Immunol Cell Biol 76, 300-317. (Pubitemid 28352760)
9. Kemp, R.A., and Ronchese, F. (2001). Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J Immunol 167, 6497-6502. (Pubitemid 33081584)
10. Kobayashi, M., Kobayashi, H., Pollard, R.B., and Suzuki, F. (1998). A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol 160, 5869-5873. (Pubitemid 28298045)
11. Lawrence, R.E., and Salgia, R. (2010). MET molecular mechanisms and therapies in lung cancer. Cell Adh Migr 4, 146-152.
12. Li, Z., Chen, L., and Qin, Z. (2009). Paradoxical roles of IL-4 in tumor immunity. Cell Mol Immunol 6, 415-422.
13. Liu, Y., He, Z., Feng, D., Shi, G., Gao, R., Wu, X., Song, W., and Yuan, W. (2011). Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol [Epub ahead of print]; DOI: 10.1089/dna.2011.1269.
14. Ma, L., Song, H., Zhang, M., and Zhang, D. (2011). Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases. DNA Cell Biol [Epub ahead of print]; DOI: 10.1089/dna.2011.1261.
15. Nakashima, H., Miyake, K., Inoue, Y., Shimizu, S., Akahoshi, M., Tanaka, Y., Otsuka, T., and Harada, M. (2002). Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 3, 107-109. (Pubitemid 38961117)
16. Paul, W.E. (1991). Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77, 1859-1870.
17. Pawlik, A., Wrzesniewska, J., Florczak, M., Gawronska-Szklarz, B., andHerczynska, M. (2005). The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 26, 48-51. (Pubitemid 41531514)
18. Rena, O., Papalia, E., Maggi, G., Oliaro, A., Ruffini, E., Filosso, P., Mancuso, M., Novero, D., and Casadio, C. (2005). World Health Organization histologic classification: an independent prognostic factor in resected thymomas. Lung Cancer 50, 59-66. (Pubitemid 41297470)
19. Rosenwasser, L.J., Klemm, D.J., Dresback, J.K., Inamura, H., Mascali,J.J,. Klinnert, M., and Borish, L. (1995). Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25, 74-78.
20. Scarel-Caminaga, R.M., Trevilatto, P.C., Souza, A.P., Brito, R.B., and Line, S.R. (2002). Frequencies of the -330(T/G) IL-2 and -590(T/C) IL-4 gene polymorphisms in a population from southeastern Brazil. Eur J Immunogenet 29, 293-296. (Pubitemid 34779666)
21. Shurin, M.R., Lu, L., Kalinski, P., Stewart-Akers, A.M., and Lotze, M.T. (1999). Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 21, 339-359. (Pubitemid 30011443)
22. Wang, W., Song, H., Liu, J., Song, B., and Cao, X. (2011). CD86 + 1057G/A Polymorphism and Susceptibility to Osteosarcoma. DNACell Biol [Epub ahead of print]; DOI: 10.1089/dna.2011.1211.
23. Yang, D., Song, H., Xu, W., Long, H., Shi, C., Jing, Z., Song, W., and Pei, B. (2011). Interleukin 4-590T/C polymorphism and susceptibility to leprosy. Genet Test Mol Biomarkers [Epub ahead of print]; DOI: 10.1089/gtmb.2011.0032.
24. Yu, H.H., Liu, P.H., Lin, Y.C., Chen, W.J., Lee, J.H., Wang, L.C., Yang, Y.H., and Chiang, B.L. (2010). Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 19, 1219-1228